Jacobs Levy Equity Management’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
|
|||||
|
2022
Q3 | $528K | Sell |
|
|||||
|
2022
Q2 | $705K | Sell |
|
|||||
|
2022
Q1 | $1.87M | Buy |
|
|||||
|
2021
Q4 | $1.79M | Buy |
|
|||||
|
2021
Q3 | $303K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $994K | Sell |
|
|||||
|
2020
Q2 | $2.23M | Sell |
|
|||||
|
2020
Q1 | $1.29M | Buy |
|
|||||
|
2019
Q4 | $1.43M | Buy |
|
|||||
|
2019
Q3 | $289K | Buy |
|
|||||
|
2019
Q2 | $378K | Sell |
|
|||||
|
2019
Q1 | $228K | Sell |
|
|||||
|
2018
Q4 | $313K | Buy |
|
|||||
|
2018
Q3 | $365K | Sell |
|
|||||
|
2018
Q2 | $439K | Buy |
|
|||||
|
2018
Q1 | $405K | Sell |
|
|||||
|
2017
Q4 | $310K | Sell |
|
|||||
|
2017
Q3 | $335K | Buy |
|
|||||
|
2017
Q2 | $205K | Buy |
|
|||||
|
2017
Q1 | $66K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $142K | Buy |
|